(Q37619960)

21 August 2017

title

European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats (English)

1 reference

21 August 2017

Cafer Adiguzel

1

1 reference

21 August 2017

Omer Iqbal

series ordinal

2

1 reference

21 August 2017

Muzaffer Demir

series ordinal

3

1 reference

21 August 2017

Jawed Fareed

series ordinal

4

1 reference

21 August 2017

publication date

22 October 2009

1 reference

Clinical and Applied Thrombosis-Hemostasis

21 August 2017

published in

1 reference

21 August 2017

volume

15

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

645-651

1 reference

Effect of genetic background on glycosylation heterogeneity in human antithrombin produced in the mammary gland of transgenic goats

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Uses of antithrombin III concentrate in congenital and acquired deficiency states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

The anti-inflammatory actions of antithrombin--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Molecular genetics of antithrombin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Pleiotropic effects of antithrombin strand 1C substitution mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Large scale production of recombinant human lactoferrin in the milk of transgenic cows

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

Hemophilia therapy and blood-borne pathogen risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

21 January 2018

Prion reduction filters.

1 reference

https://api.crossref.org/works/10.1177%2F1076029609339748

21 January 2018

Identifiers

DOI

10.1177/1076029609339748

1 reference

21 August 2017

1 reference